COPD anxiety and depression across GOLD stages.

Sourabh Jain, Satyendra Mishra, Mahendra Singh Chouhan, Sanjay Gupta, Talha Saad

Abstract read

In one paragraph

Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sourabh JainDepartment of Emergency Medicine, Bundelkhand Medical College, Sagar, Madhya Pradesh, India.

Satyendra MishraDepartment of Respiratory Medicine, Bundelkhand Medical College, Sagar, Madhya Pradesh, India.

Mahendra Singh ChouhanDepartment of Pediatrics, Bundelkhand Medical College, Sagar, Madhya Pradesh, India.

Sanjay GuptaDepartment of TB and Respiratory Diseases, Chief Medical Officer (Senior Administrative Grade), NITRD, Delhi, India.

Talha SaadDepartment of Respiratory Medicine, Bundelkhand Medical College, Sagar, Madhya Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic Obstructive Pulmonary Disease (COPD) often leads to anxiety and depression, adversely impacting patients' quality of life. Therefore, it is of interest to evaluate the prevalence and correlation of anxiety and depression among COPD patients categorized by the GOLD guidelines. Hence, a total of 160 clinically stable COPD patients were assessed for anxiety and depression using the Hindi translations of PHQ-9 and GAD-7 questionnaires. Spirometry was used for classifying COPD severity as per GOLD guidelines. Significant correlations were found between GOLD categories and levels of anxiety (Spearman's rho = 0.351, P<0.01) and depression (Spearman's rho = 0.415, P<0.01). Data shows significant correlation between COPD severity and psychological distress, underscoring the importance of integrated mental health care in COPD management.

Indexed as

anxietyChronic Obstructive Pulmonary Disease (COPD)depressionFEV1Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage

Identifiers

PMID42282396

DOI10.6026/973206300222292

PMCPMC13252303

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.